Samjin Pharm Cash Flow Quality Index
Samjin Pharm cash flow quality index. Samjin Pharm (005500) has a Cash Flow Quality Index of -0.21x as of September 2025. Operating cash flow of ₩-1.43 Billion is below net income of ₩6.84 Billion, suggesting accrual-heavy earnings not yet converted to cash. See Samjin Pharm leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Samjin Pharm (2013–2024)
Cash flow quality index of Samjin Pharm from 2013 to 2024. Historical Cash Flow Quality Index for Samjin Pharm across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 005500 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Samjin Pharm Cash Flow Quality Index by Year (2013–2024)
Samjin Pharm cash flow quality index by year from 2013 to 2024. Year-by-year earnings quality comparison for Samjin Pharm. For the full cash flow conversion analysis, see 005500 cash flow conversion.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.97x | ₩38.15 Billion | ₩39.23 Billion | ▲ +120.6% |
| 2023 | 0.44x | ₩8.33 Billion | ₩18.91 Billion | ▼ -44.2% |
| 2022 | 0.79x | ₩17.29 Billion | ₩21.89 Billion | ▼ -6.4% |
| 2021 | 0.84x | ₩23.97 Billion | ₩28.40 Billion | ▼ -1.4% |
| 2020 | 0.86x | ₩23.86 Billion | ₩27.88 Billion | ▼ -57.0% |
| 2019 | 1.99x | ₩23.63 Billion | ₩11.88 Billion | ▲ +68.8% |
| 2018 | 1.18x | ₩30.08 Billion | ₩25.53 Billion | ▲ +13.1% |
| 2017 | 1.04x | ₩37.28 Billion | ₩35.80 Billion | ▼ -35.4% |
| 2016 | 1.61x | ₩48.66 Billion | ₩30.17 Billion | ▲ +130.3% |
| 2015 | 0.70x | ₩18.94 Billion | ₩27.04 Billion | ▼ -55.2% |
| 2014 | 1.56x | ₩32.41 Billion | ₩20.72 Billion | ▲ +67.1% |
| 2013 | 0.94x | ₩7.37 Billion | ₩7.88 Billion | — |